08:55 AM EDT, 08/21/2025 (MT Newswires) -- Immuneering ( IMRX ) said Thursday it is offering about $25 million of its securities in a private placement to qualified institutional buyers.

The offering is expected to close on or about Aug. 26, the company said.

Investors agree to buy an aggregate of about 6.3 million unregistered shares of the company's class A common stock at a purchase price of $3.95 per share and accompanying purchase warrants to buy an aggregate of about 2.9 million shares of class A common stock, with each warrant representing the right to puchase one share of the company's class A common stock at an exercise price of $5.50 per share, Immuneering ( IMRX ) said.

The investors will be granted registration rights as part of the transaction, and the purchase warrants will be exerciseable for a period of five years following the date on which the class A common stock issued and issuable in the transaction are registered for resale, the company said.

Immuneering's ( IMRX ) shares were up 8% in recent Thursday premarket activity.